Infection (2018) 46:289–291 https://doi.org/10.1007/s15010-018-1142-4 EDITORIAL The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018 Johannes R. Bogner Published online: 7 May 2018 © Springer-Verlag GmbH Germany, part of Springer Nature 2018 This year’s ECCMID in Madrid convened roughly 13,000 patients in developed countries) flucloxacillin is not suffi- professionals to hear and discuss about 3500 contributions cient to result in sufficient clinical improvement by day 6. in more than 200 sessions, most of them in parallel. The Moreover, in both groups only roughly 50% reached clinical field was covered extensively in all aspects from infections cure opening the question, whether flucloxacillin can remain control over clinical microbiology, clinical infection man- the suggested first line option for cellulitis (O 1122 [3 ]). agement through vaccination and other preventive measures. A putative “DEAD box RNA helicase” gene “help”s One contribution of the European Centre for Disease Pseudomonas to be a killer: By sequencing and establishing and Prevention Control (ECDC) by Dr. Robesyn summa- a phylogenetic analysis of the core and accessory genome of rized clinical characteristics of all 37,365 cases of measles pseudomonas strains from blood stream infections a micro- reported to the ECDC from 2013 to 2017, 81% occurring biology
Infection – Springer Journals
Published: May 7, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera